|
HS Code |
990057 |
| Productname | 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole |
| Molecularformula | C10H9ClN2O2 |
| Molecularweight | 224.65 |
| Casnumber | 123665-59-8 |
| Appearance | White to off-white solid |
| Meltingpoint | 85-89°C |
| Solubility | Slightly soluble in organic solvents |
| Purity | Typically ≥98% |
| Storageconditions | Store at 2-8°C, keep container tightly closed |
| Smiles | COC1=CC=CC=C1C2=NC(=NO2)CCl |
| Inchi | InChI=1S/C10H9ClN2O2/c1-15-8-4-2-3-7(5-8)10-12-9(6-11)13-14-10/h2-5H,6H2,1H3 |
| Synonyms | 2-Methoxy-5-(chloromethyl)-1,2,4-oxadiazole |
| Hazardclass | Irritant |
As an accredited 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 25 grams, tightly sealed with a PTFE-lined cap, labeled with chemical name, formula, hazard symbols, and handling instructions. |
| Shipping | **Shipping Description:** 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole is shipped in tightly sealed containers, protected from light and moisture. Standard chemical transport regulations apply—keep at ambient temperature, away from incompatible substances. Label containers with hazard classifications and handle with suitable personal protective equipment. Ensure compliance with local, national, and international shipping guidelines. |
| Storage | Store 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-oxadiazole in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible substances such as strong oxidizers and acids. Ensure proper labeling, and restrict access to trained personnel. Handle using appropriate personal protective equipment to avoid contact and inhalation. |
Applications of 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole in Industrial Manufacturing3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole finds use in multiple high-value industrial segments due to its well-defined structural features, controlled reactivity, and specific compatibility with advanced chemical synthesis processes. As a dedicated manufacturer, we serve formulators and producers seeking controlled performance parameters and strict adherence to regulatory and performance demands in specialized downstream applications. 1. Pharmaceutical Intermediate for Targeted Molecule SynthesisMany pharmaceutical manufacturers use this oxadiazole derivative as a key intermediate in the multistep synthesis of novel heterocyclic drug candidates and targeted active pharmaceutical ingredients (APIs), particularly for CNS, antiviral, and anticancer pipelines. The compound introduces the chloromethyl group during late-stage derivatization, supporting reliable formation of essential bioactive moieties without unwanted side reactions. Our controlled production ensures batch-to-batch fidelity, which remains essential for validated medicinal chemistry workflows and large-scale GMP batch records. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient PrecursorCrop protection R&D teams utilize this oxadiazole framework as a key scaffold for preparing agrochemical actives such as fungicides and selective herbicides that require precise control of halogenation and aromatic substitution patterns. Its chloromethyl functionality supports further derivatization via alkylation, etherification, or formation of bidentate ligands for enhanced target specificity. Our strict contaminant control supports compliance in active ingredient registration portfolios worldwide. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Fluorescent Probe and Dye ManufacturingElectronics and life sciences companies deploy this oxadiazole derivative in the tailored synthesis of specialty fluorescent probes, optical markers, and sensor dyes, thanks to its electron-rich aromatic system and modifiable substitutions. It is integrated into multi-functional dye architectures to provide selective wavelength absorption, high quantum efficiency, and environmental-responsive fluorescence. Exacting purity, controlled halide content, and consistency at scale are mandatory for reproducibility in advanced photonics and bioimaging applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Polymers and High-Performance Material AdditivationEngineered polymers and compounders utilize this molecule as a reactive additive or chain-modifying building block to impart fire retardancy, thermal stability, or tailored optical characteristics in advanced thermoplastic resins and specialty coatings. Its compatibility with specific monomer types allows for covalent incorporation or controlled end-group functionalization. We provide validated purity and controlled halide residuals, ensuring predictable copolymer properties at industrial scale. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Few molecules arrive as demand-driven and technically nuanced as 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole. With more laboratories relying on high-performance oxadiazole derivatives for pushing synthetic and pharmaceutical boundaries, we recognize the need to bridge the gap between academic research and continuous industrial supply. Every batch produced at our site reflects years of refinement—not only in controlling fine-chemical reactions, but also in addressing the complexities customers experience in upscaling from bench to pilot to plant.
The molecule’s structure offers synthetic chemists both opportunity and challenge. With the methoxyphenyl ring adding electron richness, and a reactive chloromethyl handle sitting on the heterocyclic core, small changes in process parameters—solvent selection, catalyst proportions, heat profiles—shift outcomes. We see this every time a customer requests customization, or an unexpected impurity drifts above spec. For research institutions exploring new oxadiazole scaffolds, having reliable access to precisely manufactured intermediates can make the difference between a project stalling and moving forward to publication or patent.
Specifications on paper don’t tell the story of what’s waiting inside every drum or flask. Our working standard for 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole is rooted in dozens of pilot batches, dialed-in analytical routines, and feedback from chemistry teams who run actual reactions—sometimes with tiny tweaks that reveal unanticipated reactivity. While analytical metrics like HPLC purity (often >98%), moisture content, and residual solvent levels form the backbone of our release protocols, our approach is built around customer feedback. Many find that technical support around solubility, shelf stability, and side-reaction suppression dwarfs any one certificate of analysis.
Sourcing a molecule like this means facing choices about process design, quality, and risk management. As a manufacturer directly overseeing each step, our commitment is more than batch-to-batch consistency. Our team tracks temperature excursions, halogenation conditions, and washing procedures to minimize both known and obscure byproducts. Early on, we gave special attention to avoiding over-chlorination and O-demethylation during synthesis—both of which compromise downstream utility and safety. Feedback loops between lab, plant, and customer ensure that shipping material matches intended applications, whether destined for heterocycle research, agrochemical development, or high-throughput medicinal screening.
3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole serves as a flexible cornerstone for chemical space expansion. Many users leverage it to introduce oxadiazole cores into ligands, especially in the early-stage discovery of antimicrobials, kinase modulators, or CNS-active compounds. The chloromethyl group acts as a clean entry point for SN2-type nucleophilic substitutions with amines, alkoxides, or thiols—often under mild conditions. Our downstream partners have documented successful coupling to peptidomimetics and combinatorial libraries, where batch consistency permits meaningful SAR analysis and reduced false positives in screening cascades.
Researchers often face challenges translating milligram-scale protocols to multi-gram or kilogram campaigns. Purity spikes or drops, color variations (off-white to light yellow), and subtle shifts in particle size distribution can derail automated work-up. We keep detailed records of every synthesis and post-processing adjustment, noting that each batch’s “personality” will slightly differ based on ambient humidity or subtle starting material fluctuations. Our team works directly with formulation chemists and procurement managers to tune not just nominal purity but also reproducibility of yield and reaction rates.
3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole often gets compared to its analogs, such as the unsubstituted phenyl variant or derivatives bearing other electron-donating or withdrawing moieties. We notice many downstream users underestimate the impact of the methoxy group in live chemistry. This substitution raises the electron density on the aromatic ring, enhancing certain coupling reactions but requiring modified oxidation protocols in late-stage synthesis. Unlike molecules carrying bulkier or less reactive substituents, the 2-methoxyphenyl group yields consistently better conversions in Suzuki and Buchwald-Hartwig reactions, provided the process tolerates methoxy migration or decomposition at elevated temperatures.
Chloromethyl side chains also invite stricter controls around storage and handling. For instance, competing suppliers have run into issues with chloride elimination, leading to fouling and inconsistent yields. We control this by minimizing batch resident time at high temperatures and performing rapid, cold extractions post-chlorination. Such process adjustments reflect years of trial, error, and learning by doing—not just relying on published procedures.
Many industrial researchers ask about solubility profiles in different solvent systems. Our batches show solubility in polar aprotic solvents (DMF, DMSO), moderate in dichloromethane, and variable in ethers or simple hydrocarbons. This knowledge comes straight from repeated requests to support scale-up teams for slow-addition processes or formulation with solid carriers. We give honest guidance about storage under nitrogen, dryness requirements, and container selection—avoiding certain plastics that can catalyze slow degradation over weeks or months.
Recent disruptions have made sourcing specialty intermediates a gamble, with global logistics and customs tightening controls and extending lead times. We tackle these head-on by maintaining core synthesis in-house and managing safety stocks of critical starting materials. Because our operation is integrated from raw material input through to final packaging, we provide accurate lead time forecasts. Regular advance scheduling and make-to-order flexibility means research teams face fewer delays or scope changes due to inventory shortages. We’ve learned to keep real-time communication lines open—especially as customs documentation and regulatory requirements shift across importing countries.
Direct manufacturer support differs fundamentally from dealing with secondary sales channels or generic traders. Our technical team draws on hands-on process knowledge, with at least a decade of collective experience troubleshooting Grignard additions, protecting group strategies, and crystallization quirks. Many customer requests revolve around dealing with selectivity or getting a sluggish reaction to move. We offer lived advice—not just a recitation of literature conditions—guided by what has worked, failed, or had to be modified here.
Every drum and bottle we fill is traceable to specific production lots, analytical runs, and QA sign-offs. Chromatographic traces and NMR data go out with each shipment, but more importantly, we respond rapidly to any purity or performance question, pulling original process records if needed. Keeping audit trails tight and documentation transparent has earned repeat business with customers under ISO, GMP, or bespoke quality management protocols. No gaps, no surprises—except sometimes when a customer achieves a breakthrough with material that performed beyond published literature standards.
Synthesis of 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole hinges on several sensitive steps. Early on, we faced issues with incomplete conversion and color instability. Iterative process improvements—such as lowering chloromethylation temperature ranges and introducing controlled rate additions of oxidants—brought real improvements. Anyone scaling beyond 100 grams will see the difference that robust protocols make; we share these lessons openly, believing that informed buyers make better partners and safer workplaces.
Waste minimization also matters—both economically and for worker safety. Managing halogenated byproducts and ensuring compliance with local environmental codes has nudged us into investing in dedicated treatment streams, vapor recovery, and real-time air monitoring. Not every supplier can claim to have measured or acted on fugitive emissions within their fence line; we track these as a matter of course.
Our packing lines accommodate custom run sizes, with capabilities ranging from a few grams for R&D up to multi-kilo lots for process development. Feedback has taught us that standard packaging rarely fits every use case. Sometimes a customer starts with tiny quantities on short notice and later switches to bulk as a project advances toward pilot or commercial scale. We accommodate by producing to order, cutting down on shelf-time degradation and maintaining access to the freshest material. This practical approach differentiates direct production sites from bulk stockists, who often can’t guarantee age, atmosphere, or handling history of their intermediates.
No single oxadiazole derivative covers all chemists’ needs. Through direct feedback, we’ve learned how researchers working on structure-activity relationships adjust reaction plans based on unexpected reactivity. Sometimes, they discover a side product with greater utility than the planned target. We engage not only by supplying material but also by providing a sounding board for troubleshooting and new synthetic ideas. This sort of partnership turns basic procurement into a genuine source of innovation for both sides—materials flow more efficiently, problems get solved quickly, and everyone learns together.
As the focus grows on greener chemistry and process safety, we continue to evaluate safer reagents and less hazardous workups. Customers benefit from full visibility into our ongoing risk assessments and upcoming sustainability initiatives. Since regulations around halogenated intermediates continue to evolve, we keep ahead by actively monitoring policy updates and, where practical, adapting plant routines to new expectations.
Events over the past several years have shown how fragile scientific supply chains can be. For those developing the next generation of pharmaceuticals, specialty coatings, or electronic materials, missing a single intermediate can introduce costly delays and project risk. Our direct production gives customers confidence—knowing the product’s history, real-world use cases, and the people behind the process. By owning and refining each link from raw starting material to finished oxadiazole, we remove guesswork and bring stability to high-value laboratories and manufacturing lines.
Chemistry is more than following a script. Every day, real users bring us unplanned synthesis hurdles, late-stage formulation curveballs, or requests for novel impurity tracking. Because we handle the molecule and all the challenges that come with its manufacture, our commentary isn’t theoretical—it’s lived, grounded, and honed by facing the same issues day after day alongside research and development teams worldwide.
In today’s market, it’s easy to lose sight of where specialty molecules originate, especially as sourcing networks become more complex and opaque. Direct production of 3-(Chloromethyl)-5-(2-Methoxyphenyl)-1,2,4-Oxadiazole stands out due to not just the chemistry, but the transparent and responsive working relationships we’ve built with customers. We help research and development teams reach milestones, support movers in scale-up, and solve the day-to-day problems that can stall breakthrough science.
This isn’t just about supplying a compound; it’s about enabling progress—batch by batch, reaction by reaction, based on the kind of practical knowledge that never makes it to a specification sheet. As your projects stretch to new applications and greater complexity, our team looks forward to supporting the next stage—working chemist to chemist, solving challenges shoulder to shoulder, and always pushing for better quality, reliability, and scientific insight.